Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001507375 | SCV001712895 | uncertain significance | not provided | 2019-10-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001507375 | SCV002146993 | uncertain significance | not provided | 2021-12-03 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1162813). This variant has not been reported in the literature in individuals affected with COX10-related conditions. This variant is present in population databases (rs148783821, gnomAD 0.05%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 357 of the COX10 protein (p.Ala357Val). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002501736 | SCV002814622 | uncertain significance | Mitochondrial complex 4 deficiency, nuclear type 3 | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001507375 | SCV003853030 | uncertain significance | not provided | 2022-09-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |